Cargando…

Anticoagulant Therapy in Thrombosis

Detalles Bibliográficos
Autor principal:	Jorpes, J. Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oliver and Boyd 1946
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283519/ https://www.ncbi.nlm.nih.gov/pubmed/20991325

Ejemplares similares

Thrombosis and Anticoagulation Therapy in Systemic Lupus Erythematosus
por: Yuan, Wenjun, et al.
Publicado: (2022)

To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy
por: Spaccarotella, Carmen, et al.
Publicado: (2023)

Marked changes in bioprosthetic valve thrombosis by anticoagulation therapy
por: Takasaki, Akihiro, et al.
Publicado: (2019)

Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding
por: Little, Derek H.W., et al.
Publicado: (2021)

Thrombosis Prevention without Anticoagulation
por: Schmaier, Alvin H.
Publicado: (2014)

Thrombosis and anticoagulation in COVID-19
por: Ramos, Roberta Pulcheri, et al.
Publicado: (2020)

Effectiveness of anticoagulant therapy in the treatment of post-TAVI bioprosthetic thrombosis
por: Descoux, Jérémy, et al.
Publicado: (2015)

Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting
por: Notten, Pascale, et al.
Publicado: (2020)

Anticoagulation Therapy for Pregnancy-Associated Thrombosis: A Retrospective Observational Study
por: Umetsu, Michihisa, et al.
Publicado: (2022)

Safety assessment of anticoagulation therapy in patients with hemorrhagic cerebral venous thrombosis
por: Ghandehari, Kavian, et al.
Publicado: (2013)

Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
por: Güner, Ahmet, et al.
Publicado: (2021)

Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?
por: Luo, Xiaolin, et al.
Publicado: (2022)

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
por: Hayashi, Takehiro, et al.
Publicado: (2019)

Efficacy and risks of anticoagulation for cerebral venous thrombosis
por: Xu, Weilin, et al.
Publicado: (2018)

Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
por: Suda, Tsuyoshi, et al.
Publicado: (2020)

Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
por: Basili, Stefania, et al.
Publicado: (2018)

Thrombosis and Anticoagulant Therapy Among Pediatric Cancer Patients: Real-Life Data
por: Hashem, Hasan, et al.
Publicado: (2021)

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
por: Candeloro, Matteo, et al.
Publicado: (2022)

COVID-19 and its implications for thrombosis and anticoagulation
por: Connors, Jean M., et al.
Publicado: (2020)

Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis
por: Grover, Steven P., et al.
Publicado: (2022)

The Need to Anticoagulate Patients With Splenic Vein Thrombosis
por: Benjamin, Clara, et al.
Publicado: (2022)

The Role of Pharmacomechanical Endovascular Intervention for Iliofemoral Vein Thrombosis Compared to Conventional Anticoagulation Therapy
por: Kim, In-sub, et al.
Publicado: (2017)

Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis
por: Riaz, Irbaz Bin, et al.
Publicado: (2023)

The outcomes of pregnant and postpartum patients with cerebral venous sinus thrombosis after anticoagulant therapy
por: Meng, Shi-Hui, et al.
Publicado: (2021)

Electroconvulsive therapy, catatonia, deep vein thrombosis and anticoagulant treatment: a case report
por: Pérez-Balaguer, Ana, et al.
Publicado: (2021)

Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
por: Olson, Sven R., et al.
Publicado: (2019)

Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in Mesenteric Venous Thrombosis
por: Salim, S., et al.
Publicado: (2018)

Cancer‐associated thrombosis: Role of direct oral anticoagulants
por: Ikeda, Masataka, et al.
Publicado: (2018)

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
por: Miesbach, Wolfgang, et al.
Publicado: (2020)

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
por: Warrior, Surbhi, et al.
Publicado: (2020)

Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy
por: Wilson Dib, Rita, et al.
Publicado: (2018)

Recurrent venous thrombosis in an adequately anticoagulated patient with pemphigus vulgaris
por: Ames, Paul R. J., et al.
Publicado: (2016)

Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants
por: Reda, Sara, et al.
Publicado: (2020)

Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants
por: Wu, Matthew, et al.
Publicado: (2019)

Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis
por: Salehi Omran, Setareh, et al.
Publicado: (2023)

A Case of Portal Vein Thrombosis by Protein C and S Deficiency Completely Recanalized by Anticoagulation Therapy
por: Choi, Bo Kyoung, et al.
Publicado: (2011)

Ascending aorta thrombosis in a patient with COVID-19 who was already receiving anticoagulation therapy
por: Bouratzis, Vasileios, et al.
Publicado: (2023)

The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study
por: Nishimoto, Yuji, et al.
Publicado: (2022)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
por: Al-Samkari, Hanny, et al.
Publicado: (2018)

Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark
por: Klok, Frederikus A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5jhtcu6alj85264igka2hhknu0